ROC analysis allowed further reduction to a core set of 2 biomarkers (CCL11/eotaxin, IL-6) that are sufficient to discern between CRMO, healthy controls, and alternative diagnoses. The gene discussed is CCL11; the disease is chronic recurrent multifocal osteomyelitis.